Correct Answer: C. Cefazolin
Cefazolin is the gold-standard first-generation cephalosporin for surgical antibiotic prophylaxis in cardiac surgery across all major guidelines including Indian Society of Anesthesiologists (ISA) recommendations. It achieves excellent bone and tissue penetration, covers Gram-positive organisms (Staphylococcus aureus, S. epidermidis) that are the primary pathogens in surgical site infections post-cardiac surgery, and has a favorable pharmacokinetic profile with adequate serum and tissue levels when dosed 1–2 g IV at induction. The beta-lactam ring provides bactericidal activity against the most common causative organisms of prosthetic valve endocarditis and sternal wound infections. Cefazolin's narrow spectrum reduces antibiotic resistance pressure compared to broader agents, and its cost-effectiveness makes it the preferred choice in Indian healthcare settings. Dosing is typically 1 g IV at induction, with redosing every 2 hours during prolonged surgery (>2 hours) to maintain therapeutic levels. For patients with beta-lactam allergy, vancomycin or clindamycin are alternatives, but cefazolin remains the first-line agent in non-allergic patients undergoing cardiac surgery.
Why the other options are wrong
A. Erythromycin — Erythromycin is a macrolide antibiotic with poor bone and tissue penetration, making it inadequate for surgical prophylaxis in cardiac surgery. It does not reliably cover Staphylococcus species and offers no advantage over cephalosporins. Macrolides are reserved for respiratory infections and atypical organisms, not surgical site infection prevention. NBE may include this to test whether students confuse macrolides with beta-lactams for surgical prophylaxis. B. Penicillin G — Penicillin G is a narrow-spectrum penicillin effective against Gram-positive cocci but lacks the stability and tissue penetration required for surgical prophylaxis. It is rapidly cleared and does not achieve sustained therapeutic levels in bone and surgical sites. Penicillin G is used for specific infections (streptococcal, meningococcal) but is inferior to cephalosporins for surgical prophylaxis. Modern cardiac surgery guidelines have abandoned penicillin G in favor of cephalosporins. D. Azithromycin — Azithromycin is a macrolide with extended tissue penetration but lacks bactericidal activity against Staphylococcus aureus and S. epidermidis—the primary pathogens in cardiac surgical site infections. It is used for atypical respiratory infections and as a prokinetic agent, not for surgical prophylaxis. The lack of proven efficacy in preventing surgical site infections in cardiac surgery makes it an inappropriate choice despite good tissue levels.
High-Yield Facts
- Cefazolin is the DOC for surgical prophylaxis in cardiac surgery (ISA guidelines, Indian practice).
- First-generation cephalosporin covers Gram-positive cocci (S. aureus, S. epidermidis) responsible for prosthetic valve endocarditis and sternal wound infections.
- Dosing: 1 g IV at induction; redose every 2 hours if surgery >2 hours to maintain therapeutic levels.
- Macrolides (erythromycin, azithromycin) lack adequate bone/tissue penetration and are not used for surgical prophylaxis.
- Penicillin G is outdated for surgical prophylaxis; cephalosporins offer superior stability and tissue penetration.
- Vancomycin is reserved for beta-lactam-allergic patients or MRSA colonization; not first-line in non-allergic patients.
Mnemonics
CARDIAC SURGERY PROPHYLAXIS = CEPHALOSPORIN Cardiac surgery → Cefazolin (first-generation cephalosporin). Remember: Cephalosporins for surgical sites, macrolides for respiratory. SAC Rule (Staphylococcus Aureus Coverage) Surgical prophylaxis needs Antibiotics covering Cocci → Cefazolin covers S. aureus & S. epidermidis (the culprits in cardiac SSI).
NBE Trap
NBE pairs macrolides (erythromycin, azithromycin) with cardiac surgery to exploit students' confusion between respiratory prophylaxis (where macrolides are used) and surgical site infection prophylaxis (where cephalosporins are standard). The presence of "antibiotic" in the question stem may also lure students toward broad-spectrum agents rather than the narrow, targeted approach of cefazolin.
Clinical Pearl
In Indian cardiac centers, cefazolin prophylaxis is administered at induction and redosed intraoperatively to prevent surgical site infections (SSI) and prosthetic valve endocarditis—the most dreaded complications post-cardiac surgery. A single preoperative dose is insufficient for procedures lasting >2 hours; redosing every 2 hours maintains bactericidal levels in the surgical field and is standard practice in Indian cardiac ICUs.
_Reference: Harrison Ch. 297 (Surgical Infections); KD Tripathi Ch. 46 (Beta-lactams & Cephalosporins); ISA Guidelines on Preoperative Antibiotic Prophylaxis_